MEI Pharma (MEIP) Competitors $2.79 +0.04 (+1.45%) (As of 10:17 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends MEIP vs. ZIVO, ALGS, ONCY, CASI, BYSI, MURA, ATRA, VNRX, CLRB, and CELUShould you be buying MEI Pharma stock or one of its competitors? The main competitors of MEI Pharma include ZIVO Bioscience (ZIVO), Aligos Therapeutics (ALGS), Oncolytics Biotech (ONCY), CASI Pharmaceuticals (CASI), BeyondSpring (BYSI), Mural Oncology (MURA), Atara Biotherapeutics (ATRA), VolitionRx (VNRX), Cellectar Biosciences (CLRB), and Celularity (CELU). These companies are all part of the "pharmaceutical products" industry. MEI Pharma vs. ZIVO Bioscience Aligos Therapeutics Oncolytics Biotech CASI Pharmaceuticals BeyondSpring Mural Oncology Atara Biotherapeutics VolitionRx Cellectar Biosciences Celularity MEI Pharma (NASDAQ:MEIP) and ZIVO Bioscience (NASDAQ:ZIVO) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, profitability, community ranking, dividends, valuation and analyst recommendations. Which has more volatility & risk, MEIP or ZIVO? MEI Pharma has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500. Comparatively, ZIVO Bioscience has a beta of 0.17, meaning that its stock price is 83% less volatile than the S&P 500. Do analysts rate MEIP or ZIVO? MEI Pharma currently has a consensus price target of $7.00, indicating a potential upside of 150.90%. Given MEI Pharma's higher possible upside, analysts clearly believe MEI Pharma is more favorable than ZIVO Bioscience.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MEI Pharma 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00ZIVO Bioscience 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the media prefer MEIP or ZIVO? In the previous week, MEI Pharma had 3 more articles in the media than ZIVO Bioscience. MarketBeat recorded 3 mentions for MEI Pharma and 0 mentions for ZIVO Bioscience. MEI Pharma's average media sentiment score of 0.72 beat ZIVO Bioscience's score of 0.00 indicating that MEI Pharma is being referred to more favorably in the media. Company Overall Sentiment MEI Pharma Positive ZIVO Bioscience Neutral Which has better valuation & earnings, MEIP or ZIVO? MEI Pharma has higher revenue and earnings than ZIVO Bioscience. ZIVO Bioscience is trading at a lower price-to-earnings ratio than MEI Pharma, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMEI Pharma$65.30M0.28$17.78M-$6.99-0.40ZIVO Bioscience$30K2,485.00-$7.78M-$4.88-4.30 Do institutionals & insiders have more ownership in MEIP or ZIVO? 52.4% of MEI Pharma shares are owned by institutional investors. Comparatively, 12.8% of ZIVO Bioscience shares are owned by institutional investors. 3.9% of MEI Pharma shares are owned by company insiders. Comparatively, 21.5% of ZIVO Bioscience shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Is MEIP or ZIVO more profitable? MEI Pharma has a net margin of 0.00% compared to ZIVO Bioscience's net margin of -11,068.75%. ZIVO Bioscience's return on equity of 0.00% beat MEI Pharma's return on equity.Company Net Margins Return on Equity Return on Assets MEI PharmaN/A -84.80% -65.24% ZIVO Bioscience -11,068.75%N/A -2,240.92% Does the MarketBeat Community believe in MEIP or ZIVO? MEI Pharma received 302 more outperform votes than ZIVO Bioscience when rated by MarketBeat users. Likewise, 62.07% of users gave MEI Pharma an outperform vote while only 60.74% of users gave ZIVO Bioscience an outperform vote. CompanyUnderperformOutperformMEI PharmaOutperform Votes40162.07% Underperform Votes24537.93% ZIVO BioscienceOutperform Votes9960.74% Underperform Votes6439.26% SummaryMEI Pharma beats ZIVO Bioscience on 12 of the 16 factors compared between the two stocks. Ad Porter & CompanyThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry. Get MEI Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for MEIP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MEIP vs. The Competition Export to ExcelMetricMEI PharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$18.58M$6.73B$5.20B$8.97BDividend YieldN/A7.94%5.23%4.04%P/E Ratio-0.404.7285.7113.39Price / Sales0.28352.931,469.4286.49Price / Cash0.4722.8835.2935.09Price / Book0.565.604.914.96Net Income$17.78M$151.32M$117.36M$224.10M7 Day Performance-1.76%3.14%2.75%2.01%1 Month Performance-9.12%-1.67%1.71%9.79%1 Year Performance-55.00%31.88%36.01%29.97% MEI Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MEIPMEI Pharma4.572 of 5 stars$2.79+1.5%$7.00+150.9%-55.6%$18.58M$65.30M-0.40100Analyst ForecastNews CoverageZIVOZIVO BioscienceN/A$20.89-0.5%N/A+2,777.5%$74.16M$30,000.00-4.2810Gap DownALGSAligos Therapeutics4.0687 of 5 stars$20.43+1.9%$75.00+267.1%+46.7%$73.34M$15.53M-1.6290News CoverageHigh Trading VolumeONCYOncolytics Biotech2.4838 of 5 stars$0.94-1.5%$4.00+325.6%-35.9%$72.44MN/A0.0030Positive NewsGap UpCASICASI Pharmaceuticals4.4763 of 5 stars$4.62-9.4%$6.00+29.9%-29.4%$71.43M$22.06M-2.04180Positive NewsBYSIBeyondSpringN/A$1.82+4.6%N/A+94.3%$71.04M$1.75M0.0080Positive NewsGap DownMURAMural Oncology3.8271 of 5 stars$4.05+20.9%$16.00+295.1%+14.2%$68.93MN/A-0.46119Gap UpHigh Trading VolumeATRAAtara Biotherapeutics4.3019 of 5 stars$11.95+4.2%$16.67+39.5%-18.9%$68.83M$8.57M-0.46165Short Interest ↓VNRXVolitionRx1.3997 of 5 stars$0.73-7.9%$2.50+241.8%-10.8%$67.79M$770,000.000.0080Gap DownCLRBCellectar Biosciences3.0941 of 5 stars$1.62+2.2%$20.00+1,138.4%-40.9%$66.65MN/A0.0010Positive NewsCELUCelularity0.656 of 5 stars$2.96+7.2%N/A-14.3%$65.09M$22.77M0.00220Short Interest ↑Gap Down Related Companies and Tools Related Companies ZIVO Bioscience Alternatives Aligos Therapeutics Alternatives Oncolytics Biotech Alternatives CASI Pharmaceuticals Alternatives BeyondSpring Alternatives Mural Oncology Alternatives Atara Biotherapeutics Alternatives VolitionRx Alternatives Cellectar Biosciences Alternatives Celularity Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MEIP) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MEI Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MEI Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
